John H. Parrish
Oprichter bij BioVascular, Inc.
Oorsprong van het eerstegraads netwerk van John H. Parrish
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA.
7
| Private Company | Pharmaceuticals: Major | 7 |
Valley Forge Pharmaceuticals, Inc.
Valley Forge Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valley Forge Pharmaceuticals, Inc. develops ophthalmic pharmaceuticals. It is an early stage ophthalmic pharmaceutical company focused on preventing the development of myopia in children and utilizing proprietary pharmaceutical drugs to control abnormal ocular development. The company is headquartered in Irvine, CA.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John H. Parrish via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ALIGN TECHNOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Emory University | College/University | Corporate Officer/Principal | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
Stanford University | College/University | Graduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree | |
E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
Glaxo, Inc. | Corporate Officer/Principal | ||
Beecham Pharmaceuticals | Corporate Officer/Principal | ||
COLUCID PHARMACEUTICALS INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
NanoSmart Pharmaceuticals, Inc.
NanoSmart Pharmaceuticals, Inc. BiotechnologyHealth Technology NanoSmart Pharmaceuticals, Inc. is a privately-held corporation based in Laguna Hills, CA. The private company is developing nanoparticle drug delivery platforms, including utilization of anti-nuclear antibody (ANA) to enable targeted drug delivery of existing drug therapies to areas of necrosis present in virtually all solid cancer tumors. Henry J. Smith has been the CEO of the company since 2006. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Biotechnology | Corporate Officer/Principal | |
University of California, Irvine | College/University | Doctorate Degree | |
Oregon State University | College/University | Undergraduate Degree | |
Retinal Degeneration Fund | Director/Board Member | ||
Gund Arena Co. | Director/Board Member | ||
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
University of Giessen | College/University | Doctorate Degree | |
University of California San Diego | College/University | Undergraduate Degree | |
Rice University | College/University | Doctorate Degree | |
Ariceum Therapeutics GmbH
Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Binx Health Ltd.
Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
YPSOMED HOLDING AG | Medical Specialties | Director/Board Member | |
BB Biotech Ventures | Chief Executive Officer | ||
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Biotech Ventures GP Ltd.
Biotech Ventures GP Ltd. Financial ConglomeratesFinance Part of Bellevue Group AG, Biotech Ventures GP Ltd. is a venture capital fund. The company is based in St. Peter Port, UK. | Financial Conglomerates | Corporate Officer/Principal | |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Investment Managers | Corporate Officer/Principal | |
MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
binx health, inc.
binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Information Technology Services | Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
ARDVRK Technologies LLC
ARDVRK Technologies LLC Information Technology ServicesTechnology Services ARDVRK Technologies LLC develops software solutions. It focuses on augmented and virtual reality applications for healthcare, life sciences, and medical device companies. The company was founded by John O’Brien, Paul Jahn, and Michael O’Brien and is headquartered in Austin, TX. | Information Technology Services | Director/Board Member | |
Convergent Dental, Inc.
Convergent Dental, Inc. Medical SpecialtiesHealth Technology Convergent Dental, Inc. develops and manufactures dental devices. The firm develops Solea, a computer-aided, CO2 laser system for both hard and soft tissue indications. The company was founded by Nathan P. Monty in 2011 and is headquartered in Needham, MA. | Medical Specialties | Director/Board Member | |
ZoomIn Online (India) Pvt Ltd.
ZoomIn Online (India) Pvt Ltd. Internet Software/ServicesTechnology Services ZoomIn Online (India) Pvt Ltd. provides an online photo service that enables customers to store, share and print their digital photos. It allows customers around the world to upload unlimited photos and share them with friends and family. The firm also operates an online store for camera and camera accessories, including photobooks, canvases, photo prints, posters, calendars, mugs, magnets and frames. The company was founded in 2007 and is headquartered in Mumbai, India. | Internet Software/Services | Director/Board Member | |
ReVision Optics, Inc.
ReVision Optics, Inc. Electronic ComponentsElectronic Technology ReVision Optics, Inc. develops optical solutions for the treatment of presbyopia. The company also develops Raindrop Near Vision Corneal Inlay, which is a refractive surgery solution. ReVision Optics was founded by Hansen A. Yuan, Adrian Koppes and Alok Nigam in 1996 and is headquartered Lake Forest, CA. | Electronic Components | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 31 |
Zwitserland | 12 |
India | 3 |
Duitsland | 3 |
Verenigd Koninkrijk | 3 |
Sectoraal
Health Technology | 20 |
Consumer Services | 11 |
Finance | 7 |
Commercial Services | 4 |
Technology Services | 4 |
Operationeel
Director/Board Member | 56 |
Corporate Officer/Principal | 20 |
Chairman | 8 |
Independent Dir/Board Member | 7 |
Undergraduate Degree | 6 |
Sterkste connecties
- Beurs
- Insiders
- John H. Parrish
- Bedrijfsconnecties